Ethics of ongoing cancer care for patients making risky decisions
- PMID: 23277773
- PMCID: PMC3439236
- DOI: 10.1200/JOP.2012.000622
Ethics of ongoing cancer care for patients making risky decisions
Abstract
Patients who decline conventional cancer therapy yet seek to continue follow-up while pursuing alternative therapy can pose an ethical challenge. The potential benefits and harms of an ongoing clinical relationship need be assessed on a case-by-case basis. Ongoing efforts at communicating, understanding the patient’s basis for decision making, and seeking to negotiate evidence-based care that is respectful of the patient’s preferences may improve outcomes.13 However, respect for the patient’s autonomy does not require support for inappropriate care and should not require that the oncologist check his or her professional judgment at the door.
Similar articles
-
Respecting the autonomy of chronic mentally ill women in decisions about contraception.Hosp Community Psychiatry. 1993 Jul;44(7):671-4. doi: 10.1176/ps.44.7.671. Hosp Community Psychiatry. 1993. PMID: 8354506
-
Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies.Hematology Am Soc Hematol Educ Program. 2005:491-7. doi: 10.1182/asheducation-2005.1.491. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304425
-
Legal and ethical issues relating to use of complementary therapies in pediatric hematology/oncology.J Pediatr Hematol Oncol. 2006 Mar;28(3):190-3. doi: 10.1097/01.mph.0000210401.28685.57. J Pediatr Hematol Oncol. 2006. PMID: 16679948 Review.
-
Treatment decisions for breast carcinoma: patient preferences and physician perceptions.Cancer. 2002 Apr 1;94(7):2076-80. doi: 10.1002/cncr.10393. Cancer. 2002. PMID: 11932912
-
Ethical issues in integrative oncology.Hematol Oncol Clin North Am. 2008 Aug;22(4):737-53, x. doi: 10.1016/j.hoc.2008.04.009. Hematol Oncol Clin North Am. 2008. PMID: 18638699 Review.
Cited by
-
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.J Oncol Pract. 2019 Jan;15(1):44-49. doi: 10.1200/JOP.18.00432. J Oncol Pract. 2019. PMID: 30629899 Free PMC article.
-
Potential Unintended Consequences Of Recent Shared Decision Making Policy Initiatives.Health Aff (Millwood). 2019 Nov;38(11):1876-1881. doi: 10.1377/hlthaff.2019.00243. Health Aff (Millwood). 2019. PMID: 31682503 Free PMC article.
-
Integrating Shared Decision-Making into Undergraduate Oncology Education: A Pedagogical Framework.J Cancer Educ. 2024 Aug;39(4):374-382. doi: 10.1007/s13187-024-02419-8. Epub 2024 Mar 6. J Cancer Educ. 2024. PMID: 38448671 Free PMC article. Review.
-
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.BMC Med. 2024 Dec 5;22(1):578. doi: 10.1186/s12916-024-03775-4. BMC Med. 2024. PMID: 39639257 Free PMC article. Review.
-
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.HPB (Oxford). 2015 Jul;17(7):611-23. doi: 10.1111/hpb.12416. Epub 2015 May 16. HPB (Oxford). 2015. PMID: 25980326 Free PMC article.
References
-
- Siminoff LA, Step MM. A communication model of shared decision making: Accounting for cancer treatment decisions. Health Psychol. 2005;24:S99–S105. - PubMed
-
- Gostin LO. Deciding life and death in the courtroom: From Quinlan to Cruzan, Glucksberg, and Vacco—A brief history and analysis of constitutional protection of the ‘right to die’. JAMA. 1997;278:1523–1528. - PubMed
-
- American Medical Association. Chicago, IL: American Medical Association; 2011. Code of Medical Ethics: Current Opinions With Annotations 2010-2011.
-
- DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002;20:34S–38S. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical